(Q34686187)

3 August 2017

title

Indian Council of Medical Research consensus document for the management of gastric cancer (English)

1 reference

3 August 2017

0 references

Shailesh V Shrikhande

1

1 reference

3 August 2017

Bhawna Sirohi

2

1 reference

3 August 2017

Savio G Barreto

3

1 reference

3 August 2017

Raju T Chacko

4

1 reference

3 August 2017

Purvish M Parikh

5

1 reference

3 August 2017

Jeremy Pautu

6

1 reference

3 August 2017

Supreeta Arya

7

1 reference

3 August 2017

Prachi Patil

8

1 reference

3 August 2017

Srinivas C Chilukuri

9

1 reference

3 August 2017

B Ganesh

10

1 reference

3 August 2017

Tanvir Kaur

11

1 reference

3 August 2017

Deepak Shukla

12

1 reference

3 August 2017

Goura Shankar Rath

13

1 reference

3 August 2017

publication date

1 October 2014

1 reference

Indian Journal of Medical and Paediatric Oncology

3 August 2017

published in

1 reference

3 August 2017

volume

35

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

239-243

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

3 August 2017

copyright license

start time

19 July 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Management of gastric cancer in Asia: resource-stratified guidelines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Imaging in local staging of gastric cancer: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Cancer mortality in India: a nationally representative survey.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Japanese gastric cancer treatment guidelines 2010 (ver. 3).

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Pattern of cancer in adolescent and young adults--a ten year study in India.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264267

Early cancer of the stomach

26 October 2018

1 reference

12 December 2020

Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer

1 reference

12 December 2020

Resection line disease in stomach cancer. British Stomach Cancer Group

1 reference

12 December 2020

Gastric cancer: a critical analysis of surgical treatment and long term survival

1 reference

12 December 2020

Identifiers

DOI

10.4103/0971-5851.144970

1 reference

3 August 2017

1 reference

3 August 2017

1 reference